Evaluation of Perioperative Celecoxib for Hip Arthroscopy
Evaluation of Perioperative Celecoxib for Hip Arthroscopy
Celecoxib is commonly used for perioperative pain control for certain orthopaedic procedures.
 It has been shown to be successful in assisting in pain control for knee arthroscopy. It has
 not previously been studied in hip arthroscopy. This is a double blinded randomized
 controlled trial to determine the efficacy of celecoxib in perioperative pain control for hip
 arthroscopy.
This study examines the efficacy of perioperative dose of celecoxib in pain management after
 hip arthroscopy. Perioperative administration of celecoxib has been shown to improve pain
 control after knee arthroscopy, but this has not yet been studied in the hip. In this study,
 patients are randomized to receive either 400mg celecoxib or placebo 1 hour prior to
 undergoing hip arthroscopy surgery. Postoperatively, patients are monitored for pain on the
 VAS scale, narcotic use, and meeting discharge criteria. The study will enroll 100 patients.
 Patients are approached for informed consent on the day of surgery. Pain scores, narcotic
 use, and time to discharge in the celecoxib group are compared to the placebo group.
Inclusion Criteria:

 -  All patients who are undergoing a hip arthroscopy procedure at Northwestern Memorial
 Hospital with Dr. Michael Terry.

 Exclusion Criteria:

 -  Pregnant women and any patient under the age of 18 years.